Sabine Schadow Escobar

Title: The Innovative Contributions of Sabine Schadow Escobar

Introduction

Sabine Schadow Escobar is a prominent inventor based in Sammamish, WA (US). She has made significant contributions to the field of biotechnology, holding a total of 11 patents. Her work focuses on developing novel therapeutic proteins and antibodies that have the potential to address various diseases and disorders.

Latest Patents

One of her latest patents is related to Oncostatin M receptor antigen binding proteins. This invention provides anti-oncostatin M receptor-β (OSMR) antigen binding proteins, including antibodies and functional fragments, derivatives, muteins, and variants. These OSMR antigen binding proteins interfere with the binding of OSM and/or IL-31 to OSMR. They are particularly useful in studying diseases associated with OSMR and in methods of treating such diseases. Another significant patent involves BTNL3 proteins, nucleic acids, and antibodies. This invention includes novel BTNL3 proteins, multimers, fragments, fusion proteins, and variants. It also provides antibodies that can bind to BTNL3 proteins and methods for making these proteins using specific nucleic acids.

Career Highlights

Throughout her career, Sabine has worked with notable companies such as Kiniksa Pharmaceuticals, Ltd. and Immunex Corporation. Her experience in these organizations has contributed to her expertise in the development of innovative biopharmaceuticals.

Collaborations

Sabine has collaborated with esteemed colleagues, including Heather A. Arnett and Joanne Louise Viney. These partnerships have further enhanced her research and development efforts in the field of biotechnology.

Conclusion

Sabine Schadow Escobar's innovative work in developing therapeutic proteins and antibodies showcases her significant contributions to biotechnology. Her patents reflect her commitment to advancing medical science and improving treatment options for various diseases.